Showing 1 - 10 of 245
The sale of ideas (e.g. through licensing) facilitates vertical specialization and the division of labor between research and development. This specialization can improve the overall efficiency of the innovative process. However, these gains depend on the timing of the sale: the buyer of an idea...
Persistent link: https://www.econbiz.de/10009368491
European Biotechnology companies and public policy-makers face to a number of crucial problems related to the … development of Biotechnology in Europe : European industrial competitiveness, the relative under-exploitation of the European … science base in Biotechnology, poor technology transfer mechanisms and difficulties in starting 'spin-off' firms. The aim of …
Persistent link: https://www.econbiz.de/10010899740
biotechnology in Germany after 1996. The process induced by BioRegio at the territory level is analyzed over a ten-year period (1995 …
Persistent link: https://www.econbiz.de/10010736423
This paper examines how scientific and technological (S&T) human capital is transformed into financial capital through the creation of firms by scientists. The analysis is based on a database describing the positions held by 132 founders from 62 French biotech SMEs. It shows that star scientists...
Persistent link: https://www.econbiz.de/10011025841
Ex-ante regulation of transgenic crop use generally prevails, before the authorization of commercial release. This kind of regulation addresses the concerns of biosafety and coexistence, under pressure of pros and/or cons of GMO. After fifteen years of large scale use of transgenic crops...
Persistent link: https://www.econbiz.de/10008790317
China is a big country in terms of biotech achievements. It is also a rare country demonstrating crop-differentiated policies in the dissemination of the GMOs. While the release of GMOs is authorized notably for cotton in 1998, it is still prohibited for food crops. In spite of the positive...
Persistent link: https://www.econbiz.de/10008793327
The subject of this paper is the relationship between the policy-making and the innovation performance in genomics and … biomedical related biotechnologies in the national research and innovation system in France in 1990'. The aim is to highlight the … sector. Government policy has recently supported a development of the biotechnology sector by encouraging start-ups and …
Persistent link: https://www.econbiz.de/10008793478
results show that the nanotechnology transfer model is very different from that involved in biotechnology evolution: while …
Persistent link: https://www.econbiz.de/10010635074
A computable general equilibrium model is applied to evaluate the opportunity costs of not adopting Bt cotton, a genetically-modified (GM) insect resistant cotton, in Benin, Burkina- Faso, Mali, Senegal, Togo, Tanzania, and Uganda when it is adopted in other countries. Our model uniquely employs...
Persistent link: https://www.econbiz.de/10010899543
Framework Program (FP) in the area of Life sciences, Biotechnology and Biochemistry for Sustainable Non-Food. We employ …
Persistent link: https://www.econbiz.de/10010821275